ROIV
Roivant Sciences Ltd. · Healthcare
President & Immunovant CEO Eric Venker sold $7.3M of Roivant Sciences Ltd.
Sold$7,324,000
$36.62Price
200,000Shares
−11%Stake
What ROIV did after the filing
- The stock from Mon, Oct 5 open, $35.98
- −2.9%
- S&P 500, same days
- −0.1%
11 of 30 trading days so far, to the Oct 20 close.
Traded Wed, Sep 30. Filed Fri, Oct 2, 5:37 PM ET, after the close. Returns use the Oct 5 open and the Oct 20 close. Not investment advice.